NEA Management Company’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
Other funds holding XFOR
SVCM
KCM
NEA Management Company's XFOR Position: Q3 2026 in Review
NEA Management Company held its X4 Pharmaceuticals (XFOR) position steady in Q3 2026 at 3,233,743 shares worth $9.38M. The position accounts for 0.69% of the portfolio, ranked #14.
NEA Management Company first reported a position in XFOR in Q4 2017 and has held it in 27 quarters since. The position peaked at $45.8M in Q1 2018. 97 funds tracked by Wall St. Rank hold XFOR as of Q3 2026.
- NEA Management Company held 3,233,743 shares of X4 Pharmaceuticals worth $9.38M as of Q3 2026.
- NEA Management Company left its X4 Pharmaceuticals share count unchanged in Q3 2026.
- X4 Pharmaceuticals made up 0.69% of NEA Management Company's portfolio in Q3 2026, its #14 holding.
- NEA Management Company first reported a position in X4 Pharmaceuticals in Q4 2017 and has held it in 27 quarters since.
- NEA Management Company's X4 Pharmaceuticals position peaked at $45.8M in Q1 2018.
- 97 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2026.
Based on NEA Management Company's 13F filing for Q3 2026, filed 16 Nov 2026.